Abstract
Inflammation has a role in the pathogenesis of atherosclerosis, which causes hypertension. Results from some studies have suggested links between periodontal disease and atherosclerosis, but links between periodontal disease and hypertension have been seldom studied. We investigated whether periodontal disease and serum antibody level were associated with hypertension. We studied 127 patients (93 men and 34 women, mean age 68±9 years) who were admitted with ischemic heart disease to our institution. A composite periodontal risk score was calculated from five periodontal vector scores. The levels of serum antibody against Porphyromonas gingivalis (Pg) were measured. Pulse pressure, mean blood pressure (BP) and pulse wave velocity were used as indices of atherosclerosis. We divided patients into two groups according to the levels of serum antibody against Pg: higher or equal to the median (high Pg antibody group) and lower than the median (low Pg antibody group).There was no difference in the use of antihypertensive agents between the two groups. The composite periodontal risk score (P=0.0003), systolic BP (P=0.030), diastolic BP (P=0.038), pulse pressure (P=0.050) and mean BP (P=0.055) were higher in the high Pg antibody group than in the low Pg antibody group. The composite periodontal risk score (r=0.320, P=0.0003), systolic BP (r=0.212, P=0.017), diastolic BP (r=0.188, P=0.035) and mean BP (r=0.225, P=0.011) correlated with the level of serum antibody against Pg, even after adjustment for age. An elevated antibody level against Pg indicates advanced periodontal disease and suggests advancement of atherosclerosis and hypertension.
Similar content being viewed by others
Introduction
Atherosclerosis is the major cause of ischemic heart disease (IHD). Although the traditional risk factors, hypertension, dyslipidemia, diabetes and smoking, are established, they do not fully account for the risk of IHD, suggesting that other mechanisms contribute to the pathogenic process.1, 2 Emerging evidence suggests that inflammation in response to specific pathogens is an additional risk factor for atherosclerosis.3 The nature and source of the inflammation, however, remain unclear. Periodontal disease, a very common chronic infection of the tissue surrounding teeth and a significant predictive factor for IHD,4 is caused by infection with predominantly Gram-negative bacteria.
Infectious agents might also provide inflammatory stimuli that accentuate atherogenesis.5, 6 Chronic extravascular infections (for example, gingivitis, prostatitis and bronchitis) can augment extravascular production of inflammatory cytokines, which may accelerate the evolution of remote atherosclerotic lesions. Porphyromonas gingivalis (Pg) is the primary pathogenic agent of adult periodontal disease7 among the well-known periodontal pathogens, for example, Actinobacillus actinomycetemcomitans, Prevotella intermedia, Treponema denticola, Tannerella forsythensis and Pg. Antibodies against Pg, a prominent periodontal pathogen, can be harvested from atheromas during human autopsies,8, 9 as can viable bacteria.10 Animal models have demonstrated that bacterial seeding with strains of Pg accelerates the formation of aortic and coronary atherosclerotic plaques in pigs11 and aortic lesions in mice.12
Despite the high prevalence of hypertension in the general population and its prognostic importance, limited data are available on the relationship between elevated blood pressure (BP), hypertensive organ damage and periodontal disease.13 Therefore, we investigated whether periodontal disease was associated with hypertension in patients with IHD.
Methods
Study population
We studied 127 patients who were admitted with IHD. There were 93 men and 34 women, with a mean age of 68±9 years. All patients with IHD had angiographic documentation of >50% organic stenosis in one or more major coronary arteries, or had a history of percutaneous coronary intervention or coronary artery bypass grafting.
Patients with heart failure, valvular heart disease, cardiomyopathy, severe arrhythmia and infection were excluded from this study. Written informed consent was obtained from each patient. The study protocol was in agreement with the guidelines of the ethics committees at our institutions.
Blood sampling
Samples for serum antibody levels against Pg were obtained from an antecubital vein in all patients on admission. All blood samples were immediately centrifuged at 3000 r.p.m. for 10 min at 4 °C, and aliquots of samples were stored at −80 °C until analysis.
Enzyme-linked immunosorbent assay
Serum antibody levels against Pg were measured by two technicians blinded to the patients’ characteristics. An enzyme-linked immunosorbent assay was used to measure the serum levels of IgG antibody against Pg (Pg-IgG) and an antibody titer was grown in Modified Gifu anaerobic medium (Nissui Pharmaceutical, Tokyo, Japan) broth under anaerobic conditions at 37 °C for 2 days. Bacteria were washed in phosphate-buffered saline (PBS) and suspended at an optical density of 0.6 (at 600 nm). After a 1:100 dilution in PBS, 100 μl aliquots of the suspension were incubated at 4 °C overnight in 96-well microtiter plates Breakable EB (Thermo Electron, Vantaa, Finland) with a cover. Plates were washed three times with PBS, and nonspecific binding was blocked with 350 μl of 2% bovine serum albumin, 5% sucrose and 0.1% sodium azide in PBS and incubated covered at 37 °C for 4 h. The plates were then sealed up and stored in aluminum bags at 4 °C until the assays.
All serum samples and reference serum were diluted in pH 7.0 1 mol l−1 phosphoric acid buffer solution (PABS) containing 1% bovine serum albumin, 0.1% sodium azide, 5 mmol l−1 EDTA-Na2 and 5 mmol l−1 MgCl2. Reference IgG was purified with a Protein G column (Amersham Biosciences, Uppsala, Sweden) from high IgG titer serum against Pg, and was used to create a standard curve to calculate arbitrary enzyme-linked immunosorbent assay units. Reference IgG was diluted from 10- to 390-fold in PABS. Each patient’s serum and the reference IgG were diluted 420-fold in PABS. Aliquots (100 μl) of each dilution of patient or reference IgG were added in duplicate to the wells, and plates were incubated covered at room temperature for 1 h. After washing six times with PBS containing 0.05% tween-20, the wells were incubated with 100 μl of antihuman IgG labeled with peroxidase (DakoCytomation, Glostrup, Denmark) at room temperature for 1 h covered. Plates were washed eight times in PBS containing 0.05% tween-20 and incubated with peroxidase substrate (3,3′,5,5′-tetramethylbenzidine; DakoCytomation) at room temperature for 30 min. The reaction was stopped by the addition of 100 μl 2 N H2SO4 and the optical density was read at 450 nm and a subwavelength of 650 nm using a Dynatech MR 5000 plate reader (Dynatech, Yokohama, Japan). A standard curve of the optical density of reference IgG was plotted against the serum dilution. Individual serum IgG antibody levels were calculated from the IgG reference curves and expressed as relative arbitrary enzyme-linked immunosorbent assay units. We then divided study patients into two groups according to the serum antibody values. Patients with serum antibody values greater than or equal to the median were assigned to high Pg-IgG group, and those with values lower than the median were assigned to low Pg-IgG group.
Periodontal examination
All patients received a thorough periodontal examination comprising a full-mouth series of dental radiographs and a comprehensive oral examination with assessments of the presence of plaque, bleeding on probing and pocket probing depths (at four surfaces per tooth: mesiobuccal, mid-buccal, distobuccal and mid-lingual). The proportional distributions of the presence of plaque, bleeding on probing and pocket probing depth (<4.0, 4.0–5.0 and ⩾6 mm) were calculated and used as subject-based data for the analysis. The number of teeth with visible signs of gingival recession and the number of remaining teeth were also accounted for. A dentist who was blinded to patients’ characteristics evaluated the periodontal status based on the assessments and radiographs.
Periodontal risk scores based on vector scores
We calculated periodontal scores for all patients based on the data sheets written by the dentist, while referring to the periodontal pentagon risk diagram reported by Renvert et al.14 Briefly, the five vectors were the following: (1) the proportion of sites with bleeding on probing, (2) the number of sites with a pocket probing depth ⩾6.0 mm, (3) the number of teeth lost in the past deducted from a total of 28 teeth, (4) the proportion of mesial/distal sites with evidence of a distance from the cement–enamel junction to bone level (bone loss) greater than or equal to half the tooth length and (5) smoking status with regard to packs per year. The five vector scores were calculated, and the total was used as the composite periodontal risk score.
Measurement of pulse wave velocity
We used pulse wave velocity (PWV) as the index for atherosclerosis. A medical technologist measured the PWV and BP of each subject twice using a PWV/ABI device (Nippon Colin, Komaki, Japan) while the subject was at rest in a supine position. This device, approved by the US Food and Drug Administration as VP-2000/1000, can monitor bilateral brachial and ankle pressure wave forms.
Statistical analysis
Data are given as mean±s.d. or median. The comparisons of continuous data between the two groups were performed with an unpaired t-test for patient characteristics or Mann–Whitney U-test for periodontal scores and antibody levels. The frequency data between the two groups were compared by the χ2-test. Linear regression analysis was used to determine the correlation between two measurements. Probability levels <0.05 were considered statistically significant.
Results
Patient characteristics
All study patients had at least one coronary risk factor. Of the study patients, 78 (61.4%) were diagnosed with hypertension, 58 (45.7%) with diabetes mellitus, 29 (22.8%) with impaired glucose tolerance and 87 (68.5%) with dyslipidemia. There were 21 (16.5%) current smokers and 47 (37.0%) past smokers. There were 117 (92.1%) patients using antihypertensive agents, and the average numbers of antihypertensive agents used were 1.8±0.9 and 1.8±1.0 in the high Pg-IgG and low Pg-IgG groups, respectively. There was no significant difference in the frequency of each hypertensive agent between the groups. A comparison of clinical characteristics according to serum antibody levels is shown in Table 1. There were no significant differences in the clinical characteristics, except for age, between the high Pg-IgG group and the low Pg-IgG group.
Periodontal risk score and serum antibody values
The composite periodontal risk score was higher in the high Pg-IgG group than in the low Pg-IgG group (P=0.0003; Table 2), and it correlated with Pg-IgG levels (r=0.320, P=0.0003; Figure 1a). In addition, the vector score for the proportion of sites with bleeding on probing was higher in the high Pg-IgG group than in the low Pg-IgG group (P=0.001; Table 2), and it correlated with Pg-IgG (r=0.273, P=0.002; Table 3). The vector score for the number of sites with a pocket probing depth ⩾6.0 mm was higher in the high Pg-IgG group than in the low Pg-IgG group (P=0.0001), and this correlated with Pg-IgG (r=0.314, P=0.0004; Table 3). The vector score for bone loss greater than or equal to half the tooth length was higher in the high Pg-IgG group than in the low Pg-IgG group (P=0.006; Table 2), and it correlated with Pg-IgG (r=0.307, P=0.0005; Table 3). In addition, the periodontal risk score significantly correlated with Pg-IgG, even after adjustment for age (Table 3).
BP and serum antibody values
Systolic BP was higher in the high Pg-IgG group than in the low Pg-IgG group (P=0.030; Table 2), and it correlated with Pg-IgG levels (r=0.212, P=0.017; Figure 1b). Diastolic BP was also higher in the high Pg-IgG group than in the low Pg-IgG group (P=0.038), and it correlated with Pg-IgG (r=0.188, P=0.035; Figure 1c). In addition, systolic and diastolic BP remained correlated with Pg-IgG after adjustment for age (Table 3).
Atherosclerotic index and serum antibody values
Pulse pressure was higher in the high Pg-IgG group than in the low Pg-IgG group (P=0.050; Table 2). Mean BP tended to be higher in the high Pg-IgG group than in the low Pg-IgG group (P=0.055; Table 2), and it correlated with Pg-IgG (r=0.225, P=0.011; Figure 1d), even after adjustment for age (Table 3). Mean PWV tended to be higher in the high Pg-IgG group than in the low Pg-IgG group (P=0.096; Table 2), and tended to correlate with Pg-IgG (r=0.171, P=0.067; Table 3). Pulse pressure and PWV tended to correlate with Pg-IgG after adjustment for age.
BP and atherosclerotic index
Systolic BP correlated with pulse pressure (r=0.786, P<0.0001), mean BP (r=0.878, P<0.0001) and PWV (r=0.369, P<0.0001). Diastolic BP correlated with mean BP (r=0.843, P<0.0001) and PWV (r=0.183, P=0.0483).
Discussion
Our results showed that the composite periodontal risk score was higher in the high Pg-IgG group than in the low Pg-IgG group. The level of serum antibody against Pg significantly correlated with periodontal risk score, which is an index for the severity of periodontal disease.14 This finding is consistent with previously reported data showing that high antibody levels against Pg are strongly associated with periodontitis.15 We previously demonstrated that levels of antibody against P. intermedia correlated with the composite periodontal risk score in patients with acute coronary syndrome.16 In the present study, serum levels of antibody against Pg were associated with three vector scores (the proportion of sites with bleeding on probing, the number of sites with a pocket probing depth ⩾6.0 mm and bone loss greater than or equal to half the tooth length) and were significantly associated with the composite periodontal risk score. Thus, these data indicate that the serum level of antibody against Pg reflects the severity of periodontal disease.
Our data demonstrated that systolic and diastolic BP were higher in the high Pg-IgG group than in the low Pg-IgG group, and they correlated with Pg-IgG levels. Current epidemiological evidence also supports the association between periodontal disease and BP. A recent large study on data derived from the Third National Health and Nutrition Examination Survey showed a positive linear relationship between systolic BP and increased severity of periodontal disease.17 Another study reported that study patients with elevated antibodies against Pg and A. actinomycetemcomitans had a higher systolic BP.18 It has also been reported that etiological bacterial burden was positively associated with both systolic and diastolic BP.19 These findings are consistent with our data showing an association between BP and the level of serum antibody against Pg.
The intima-media wall thickness (IMT) of the carotid artery, pulse pressure, mean BP and PWV are common indices of clinical atherosclerosis. Several studies reported that IMT was associated with the severity of periodontal disease.20, 21 Pulse pressure serves as an indicator of large-artery stiffness, whereas mean BP denotes peripheral resistance.22 Although PWV is an atherosclerotic index, as well as IMT,23 the relationship of periodontal disease to subclinical measures of atherosclerosis, such as PWV, has not been examined. In this study, we evaluated the association with pulse pressure, mean BP and PWV. Pulse pressure was higher in the high Pg-IgG group than in the low Pg-IgG group. Similarly, mean BP and PWV tended to be higher in the high Pg-IgG group than in the low Pg-IgG group. These results suggest that atherosclerotic indices, including pulse pressure, mean BP and PWV, are related to the serum level of antibody against Pg.
Several periodontal organisms, including some periodontopathic bacteria, have been detected directly within the atherosclerotic plaque lesion of the vessel wall.8, 24 Furthermore, periodontal organisms such as Pg have been reported to induce several pathological responses25 and, in an animal model, long-term systemic injection of Pg was reported to accelerate atherogenic plaque progression.26 These findings are consistent with the concept that inflammation has an important role in the development of atherosclerosis.27 Another possibility is that periodontal pathogen accelerates atheroma formation by deteriorating lipid metabolism.28
Dustan29 showed that hypertension and atherosclerosis are intimately associated; hypertension leads to atherosclerosis, and less frequently, atherosclerosis begets hypertension. In our data, systolic BP was actually correlated with PWV, pulse pressure and mean BP. Elevated systolic BP was part of the mechanism by which the periodontal pathogen response might influence atherosclerosis.18
Limitation of this study is that study subjects are not a general population but IHD patients. In this study, we could show the relationship between periodontal disease and atherosclerosis in a relatively small population. In a general population, we may need to study in a large population to conform the relationship because they have less-advanced atherosclerosis than IHD patients.
In conclusion, our results suggest that an elevated level of antibody against Pg indicates advanced periodontal disease and suggests advancement of atherosclerosis and hypertension.
References
Ross R . Atherosclerosis—an inflammatory disease. N Engl J Med 1999; 340: 115–126.
Vita JA, Loscalzo J . Shouldering the risk factor burden: infection, atherosclerosis, and the vascular endothelium. Circulation 2002; 106: 164–166.
Epstein SE, Zhou YF, Zhu J . Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999; 100: e20–e28.
Oe Y, Soejima H, Nakayama H, Fukunaga T, Sugamura K, Kawano H, Sugiyama S, Matsuo K, Shinohara M, Izumi Y, Ogawa H . Significant association between score of periodontal disease and coronary artery disease. Heart Vessels 2009; 24: 103–107.
Libby P, Egan D, Skarlatos S . Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997; 96: 4095–4103.
Danesh J, Collins R, Peto R . Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350: 430–436.
Holt SC, Ebersole J, Felton J, Brunsvold M, Kornman KS . Implantation of bacteroides gingivalis in nonhuman primates initiates progression of periodontitis. Science 1988; 239: 55–57.
Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ . Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000; 71: 1554–1560.
Chiu B . Multiple infections in carotid atherosclerotic plaques. Am Heart J 1999; 138: S534–S536.
Kozarov EV, Dorn BR, Shelburne CE, Dunn WA, Progulske-Fox A . Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler Thromb Vasc Biol 2005; 25: e17–e18.
Brodala N, Merricks EP, Bellinger DA, Damrongsri D, Offenbacher S, Beck J, Madianos P, Sotres D, Chang YL, Koch G, Nichols TC . Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol 2005; 25: 1446–1451.
Lalla E, Lamster IB, Hofmann MA, Bucciarelli L, Jerud AP, Tucker S, Lu Y, Papapanou PN, Schmidt AM . Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein e-null mice. Arterioscler Thromb Vasc Biol 2003; 23: 1405–1411.
Angeli F, Verdecchia P, Pellegrino C, Pellegrino RG, Pellegrino G, Prosciutti L, Giannoni C, Cianetti S, Bentivoglio M . Association between periodontal disease and left ventricle mass in essential hypertension. Hypertension 2003; 41: 488–492.
Renvert S, Ohlsson O, Persson S, Lang NP, Persson GR . Analysis of periodontal risk profiles in adults with or without a history of myocardial infarction. J Clin Periodontol 2004; 31: 19–24.
Dye BA, Herrera-Abreu M, Lerche-Sehm J, Vlachojannis C, Pikdoken L, Pretzl B, Schwartz A, Papapanou PN . Serum antibodies to periodontal bacteria as diagnostic markers of periodontitis. J Periodontol 2009; 80: 634–647.
Soejima H, Oe Y, Nakayama H, Matsuo K, Fukunaga T, Sugamura K, Kawano H, Sugiyama S, Shinohara M, Izumi Y, Ogawa H . Periodontal status and Prevotella intermedia antibody in acute coronary syndrome. Int J Cardiol 2009; 137: 304–306.
Tsakos G, Sabbah W, Hingorani AD, Netuveli G, Donos N, Watt RG, D’Aiuto F . Is periodontal inflammation associated with raised blood pressure? Evidence from a national US survey. J Hypertens 2010; 28: 2386–2393.
Colhoun HM, Slaney JM, Rubens MB, Fuller JH, Sheiham A, Curtis MA . Antibodies to periodontal pathogens and coronary artery calcification in type 1 diabetic and nondiabetic subjects. J Periodontal Res 2008; 43: 103–110.
Desvarieux M, Demmer RT, Jacobs DR, Rundek T, Boden-Albala B, Sacco RL, Papapanou PN . Periodontal bacteria and hypertension: the oral infections and vascular disease epidemiology study (INVEST). J Hypertens 2010; 28: 1413–1421.
Beck JD, Elter JR, Heiss G, Couper D, Mauriello SM, Offenbacher S . Relationship of periodontal disease to carotid artery intima-media wall thickness: the atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb Vasc Biol 2001; 21: 1816–1822.
Lopez-Jornet P, Berna-Mestre JD, Berna-Serna JD, Camacho-Alonso F, Fernandez-Millan S, Reus-Pintado M . Measurement of atherosclerosis markers in patients with periodontitis: a case-control study. J Periodontol 2012; 83: 690–698.
Franklin SS, Lopez VA, Wong ND, Mitchell GF, Larson MG, Vasan RS, Levy D . Single versus combined blood pressure components and risk for cardiovascular disease: the framingham heart study. Circulation 2009; 119: 243–250.
Tzortzis S, Ikonomidis I, Lekakis J, Papadopoulos C, Triantafyllidi H, Parissis J, Trivilou P, Paraskevaidis I, Anastasiou-Nana M, Kremastinos DT . Incremental predictive value of carotid intima-media thickness to arterial stiffness for impaired coronary flow reserve in untreated hypertensives. Hypertens Res 2010; 33: 367–373.
Okuda K, Ishihara K, Nakagawa T, Hirayama A, Inayama Y . Detection of treponema denticola in atherosclerotic lesions. J Clin Microbiol 2001; 39: 1114–1117.
Dorn BR, Dunn WA, Progulske-Fox A . Invasion of human coronary artery cells by periodontal pathogens. Infect Immun 1999; 67: 5792–5798.
Li L, Messas E, Batista EL, Levine RA, Amar S . Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein e-deficient murine model. Circulation 2002; 105: 861–867.
Libby P . Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012; 32: 2045–2051.
Maekawa T, Takahashi N, Tabeta K, Aoki Y, Miyashita H, Miyauchi S, Miyazawa H, Nakajima T, Yamazaki K . Chronic oral infection with porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile. PLoS One 2011; 6: e20240.
Dustan HP . George lyman duff memorial lecture. Atherosclerosis complicating chronic hypertension. Circulation 1974; 50: 871–879.
Acknowledgements
This study was supported in part by a grant-in-aid for scientific research (No. C23591051) from the Ministry of Education, Science, and Culture in Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hanaoka, Y., Soejima, H., Yasuda, O. et al. Level of serum antibody against a periodontal pathogen is associated with atherosclerosis and hypertension. Hypertens Res 36, 829–833 (2013). https://doi.org/10.1038/hr.2013.46
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/hr.2013.46
Keywords
This article is cited by
-
Association between periodontitis and pulse wave velocity: a systematic review and meta-analysis
Clinical Oral Investigations (2021)
-
Relationship between the burden of major periodontal bacteria and serum lipid profile in a cross-sectional Japanese study
BMC Oral Health (2018)
-
Elevated serum concentrations of lipopolysaccharide binding protein might prolong sleep stage one in middle-aged hypertensive males
Sleep and Breathing (2017)
-
Serum antibody levels against Porphyromonas gingivalis in patients with and without rheumatoid arthritis – a systematic review and meta-analysis
Clinical Oral Investigations (2017)
-
Arterial stiffness in periodontitis patients and controls
Journal of Human Hypertension (2016)